Are treatments for the neurological effects of COVID on the horizon? edergenzinger checks out recent research findings.
When researchers analyzed serum samples, they found that samples from COVID-19 patients with delirium had a six-fold higher level of IL6. Furthermore, treating the brain cells with the delirium serum samples caused the brain cells to produce IL12 and IL13. These two cytokines may form a cascade generated by brain cells in response to inflammation in the body created by IL6.
These neurological symptoms are very concerning for patients and their families, and the hope is that our research can help identify which treatments would be most appropriate to lessen or prevent these symptoms.Source: Image by martinez from Pixabayhave immediate application in developing pharmacological approaches to treat neurological symptoms brought on by COVID-19.
IL12: IL12 inhibitors such as ustekinumab and briakinumab have been used to treat inflammatory bowel disease.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
66 percent of OSU students feeling burnout.\u00a0Mental heath strained on all levels |OpinionMore than two years into COVID-19 pandemic, a mental health pandemic rages, Bernadette Melnyk writes.
Consulte Mais informação »
New bivalent booster shots available for kids as young as 5 at Chicago clinics, pharmacies, and moreThe new boosters target both the original COVID-19 strain and the omicron variant.
Consulte Mais informação »
Peter Hotez says new 'Scrabble variants' like BQ.1.1 could bring another winter COVID wave to TexasWill new variants in Europe create another COVID-19 wave in the States early next year? Dr. Peter Hotez weighs in on what the future may bring.
Consulte Mais informação »
Gov. Newsom to End California's COVID-19 State of Emergency in FebruaryCalifornia’s COVID-19 state of emergency will end in February, the Governor’s Office announced Monday.
Consulte Mais informação »